BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Western blot showed that the CRBN-based PROTAC molecule PROTAC 22 (Table 1) could degrade the BCR-ABL fusion protein and c-ABL-expressed receptors in K562 CML cells.